Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

906 recalls, newest first

Class I · High risk

Amikacin Sulfate Injection

Non-Sterility:Microbial growth detected in sub lot of Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP 10mg/2mL (5mg/mL) .

Terminated Sterility / contamination Heritage Pharmaceuticals, Inc. NDC 23155-290-32 D-1398-2019
Class I · High risk

Prochlorperazine Edisylate Injection

Non-Sterility:Microbial growth detected in sub lot of Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP 10mg/2mL (5mg/mL) .

Terminated Sterility / contamination Heritage Pharmaceuticals, Inc. NDC 23155-294-31 D-1397-2019
Class II · Moderate risk

Ketorolac Tromethamine Injection

Lack of Sterility Assurance: Microbial growth detected during a routine simulation of the manufacturing process, which represents the potential introduction of microorganisms into the products.

Terminated Sterility / contamination Sagent Pharmaceuticals Inc D-1274-2019

Recalls by year